During the last session, Staar Surgical Co (NASDAQ:STAA)’s traded shares were 0.82 million, with the beta value of the company hitting 0.76. At the end of the trading day, the stock’s price was $17.79, reflecting an intraday gain of 1.25% or $0.22. The 52-week high for the STAA share is $52.68, that puts it down -196.12 from that peak though still a striking 24.11% gain since the share price plummeted to a 52-week low of $13.50. The company’s market capitalization is $877.50M, and the average intraday trading volume over the past 10 days was 0.97 million shares, and the average trade volume was 1.07 million shares over the past three months.
Staar Surgical Co (STAA) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.69. STAA has a Sell rating from 1 analyst(s) out of 13 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 11 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.58.
Staar Surgical Co (NASDAQ:STAA) trade information
Staar Surgical Co (STAA) registered a 1.25% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.25% in intraday trading to $17.79, hitting a weekly high. The stock’s 5-day price performance is 0.40%, and it has moved by 0.57% in 30 days. Based on these gigs, the overall price performance for the year is -50.58%. The short interest in Staar Surgical Co (NASDAQ:STAA) is 4.43 million shares and it means that shorts have 3.36 day(s) to cover.
The consensus price target of analysts on Wall Street is $48, which implies an increase of 62.94% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $45.03 and $85 respectively. As a result, STAA is trading at a discount of -377.8% off the target high and -153.12% off the low.
Staar Surgical Co (STAA) estimates and forecasts
In the rating firms’ projections, revenue will decrease -16.93% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 40.33M as predicted by 11 analyst(s). Meanwhile, a consensus of 11 analyst(s) estimates revenue growth to 41.1M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 77.36M and 99M respectively. In this case, analysts expect current quarter sales to shrink by -47.87% and then drop by -58.49% in the coming quarter.
While earnings are projected to return -451.72% in 2025, the next five years will return 20.23% per annum.
STAA Dividends
Staar Surgical Co is due to release its next quarterly earnings on 2025-Feb-10. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Staar Surgical Co (NASDAQ:STAA)’s Major holders
Staar Surgical Co insiders own 0.55% of total outstanding shares while institutional holders control 102.65%, with the float percentage being 103.22%. BROADWOOD CAPITAL INC is the largest shareholder of the company, while 303.0 institutions own stock in it. As of 2024-06-30, the company held over 10.77 million shares (or 21.9196% of all shares), a total value of $512.68 million in shares.
The next largest institutional holding, with 7.49 million shares, is of BLACKROCK INC.’s that is approximately 15.2438% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $356.54 million.
Also, the Mutual Funds coming in first place with the largest holdings of Staar Surgical Co (STAA) shares are iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . Data provided on Feb 28, 2025 indicates that iShares Trust-iShares Core S&P Small-Cap ETF owns about 3.14 shares. This amounts to just over 6.37 percent of the company’s overall shares, with a $55.88 million market value. The same data shows that the other fund manager holds slightly less at 1.55, or about 3.14% of the stock, which is worth about $27.54 million.
